Table 1.
Advantages: insulin | Advantages: incretins | Advantages: combination insulin and linagliptin |
---|---|---|
Most effective blood glucose-lowering therapy39 | Safe and effective improvement of glycemic control26 | Reduction of hypoglycemia risk30,31 |
Most clinical experience39 | Blood sugar−dependent mode of action19,20 | Reduction of insulin-associated weight gain, by decreasing insulin dose25,32 |
No maximum dose-effect threshold39 | Counter-regulation of hypoglycemia30,31 | |
Beneficial effects on hypertriglyceridemia18 | No weight gain25,32 Primarily targets postprandial glycemia8 Oral administration26 |
|
| ||
Disadvantages: insulin | Disadvantages: incretins | Disadvantages: combination insulin and linagliptin |
| ||
Blood sugar−independent mode of action15 | Lack of long-term safety evaluations8 | Lack of long-term safety evaluations8 |
Mode of administration39 | Decline of insulin-releasing effect with progressive beta cell failure24 | |
Associated with weight gain32 | ||
High risk for hypoglycemia29 |